-
Thu06Aug2026Sat08Aug2026
-
Wed02Sep2026Fri04Sep2026
-
Tue29Sep2026Fri02Oct2026Dubai, United Arab Emirates
-
Wed30Sep2026Sun04Oct2026
-
Wed30Sep2026Sun04Oct2026
-
Wed07Oct2026Fri09Oct2026
-
Sun11Oct2026Thu15Oct2026
-
Mon12Oct2026Fri16Oct2026
Latest News
Galaxy Therapeutics lands CE mark for Seal embolisation system
Galaxy Therapeutics today announced that it has received a CE mark under the European Medical Device Regulation (MDR) for the Seal embolisation system following...
Features
Why mechanical angioplasty deserves a place in the vasospasm treatment algorithm
As part of a PhD programme supervised by Boris Lubicz, Adrien Guenego (both Brussels, Belgium) recently conducted the first prospective randomised trial directly evaluating...
Who funds stroke trials in Europe—and why this matters more than...
Following the release of new findings from a survey conducted by the European Stroke Organisation Trials Alliance (ESOTA) on how clinical trials in stroke...
Videos
In the first instalment of a two-part roundtable discussion on the fallout from CREST-2, William Gray (Main Line Health, Philadelphia, USA) is joined by Sonya Noor (Buffalo Endovascular and Vascular Surgical Associates, Buffalo, USA) and Richard Bulbulia (University of...
